Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAMRAT PHARMA vs CHANDRA BHAGAT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SAMRAT PHARMA CHANDRA BHAGAT PHARMA SAMRAT PHARMA/
CHANDRA BHAGAT PHARMA
 
P/E (TTM) x 4,683.0 - - View Chart
P/BV x 1.6 2.6 62.6% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 SAMRAT PHARMA   CHANDRA BHAGAT PHARMA
EQUITY SHARE DATA
    SAMRAT PHARMA
Mar-23
CHANDRA BHAGAT PHARMA
Mar-23
SAMRAT PHARMA/
CHANDRA BHAGAT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,250136 919.1%   
Low Rs33283 400.0%   
Sales per share (Unadj.) Rs1,005.3158.5 634.3%  
Earnings per share (Unadj.) Rs53.81.2 4,490.1%  
Cash flow per share (Unadj.) Rs55.91.3 4,154.2%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs204.336.4 561.5%  
Shares outstanding (eoy) m3.097.55 40.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.80.7 114.0%   
Avg P/E ratio x14.791.2 16.1%  
P/CF ratio (eoy) x14.181.3 17.4%  
Price / Book Value ratio x3.93.0 128.7%  
Dividend payout %1.90-   
Avg Mkt Cap Rs m2,444826 295.8%   
No. of employees `000NANA-   
Total wages/salary Rs m1113 80.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,1061,197 259.6%  
Other income Rs m53 163.1%   
Total revenues Rs m3,1111,200 259.3%   
Gross profit Rs m23932 752.9%  
Depreciation Rs m61 579.3%   
Interest Rs m1222 56.1%   
Profit before tax Rs m22512 1,938.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m593 2,295.7%   
Profit after tax Rs m1669 1,837.7%  
Gross profit margin %7.72.7 290.1%  
Effective tax rate %26.222.1 118.6%   
Net profit margin %5.40.8 707.6%  
BALANCE SHEET DATA
Current assets Rs m986589 167.4%   
Current liabilities Rs m528269 195.8%   
Net working cap to sales %14.826.7 55.3%  
Current ratio x1.92.2 85.5%  
Inventory Days Days80 2,400.0%  
Debtors Days Days602250 241.1%  
Net fixed assets Rs m1757 2,408.7%   
Share capital Rs m3175 41.0%   
"Free" reserves Rs m601199 301.3%   
Net worth Rs m631275 229.8%   
Long term debt Rs m039 0.0%   
Total assets Rs m1,162606 191.7%  
Interest coverage x19.31.5 1,261.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x2.72.0 135.4%   
Return on assets %15.45.1 300.2%  
Return on equity %26.33.3 799.4%  
Return on capital %37.610.7 351.8%  
Exports to sales %4.148.1 8.5%   
Imports to sales %83.30-   
Exports (fob) Rs m127576 22.0%   
Imports (cif) Rs m2,587NA-   
Fx inflow Rs m127576 22.0%   
Fx outflow Rs m2,5877 37,111.3%   
Net fx Rs m-2,460569 -432.4%   
CASH FLOW
From Operations Rs m-9453 -179.3%  
From Investments Rs m-30-1 5,093.2%  
From Financial Activity Rs m96-44 -215.9%  
Net Cashflow Rs m-288 -375.1%  

Share Holding

Indian Promoters % 48.6 68.7 70.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.2 2.2 145.9%  
FIIs % 0.0 1.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 51.4 31.3 164.0%  
Shareholders   8,065 134 6,018.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SAMRAT PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SAMRAT PHARMA vs CHANDRA BHAGAT PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SAMRAT PHARMA vs CHANDRA BHAGAT PHARMA Share Price Performance

Period SAMRAT PHARMA CHANDRA BHAGAT PHARMA S&P BSE HEALTHCARE
1-Day -1.87% -1.04% 1.18%
1-Month -10.12% -28.89% -0.75%
1-Year -2.44% -2.06% 61.82%
3-Year CAGR 34.42% 33.64% 18.16%
5-Year CAGR 38.09% 12.92% 19.79%

* Compound Annual Growth Rate

Here are more details on the SAMRAT PHARMA share price and the CHANDRA BHAGAT PHARMA share price.

Moving on to shareholding structures...

The promoters of SAMRAT PHARMA hold a 48.6% stake in the company. In case of CHANDRA BHAGAT PHARMA the stake stands at 68.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SAMRAT PHARMA and the shareholding pattern of CHANDRA BHAGAT PHARMA.

Finally, a word on dividends...

In the most recent financial year, SAMRAT PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 1.9%.

CHANDRA BHAGAT PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of SAMRAT PHARMA, and the dividend history of CHANDRA BHAGAT PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.